Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
about
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomographyPositron Emission Tomography in Breast CancerPositron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected ReviewState-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETImaging metabolic heterogeneity in cancerRole of positron emission tomography for the monitoring of response to therapy in breast cancerNeoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomographyDiffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.Breast cancer attributable costs in Germany: a top-down approach based on sickness funds dataVariability of dynamic 18F-FDG-PET data in breast cancer xenografts.Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice.Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.Respiratory-gated PET/CT versus delayed images for the quantitative evaluation of lower pulmonary and hepatic lesions.Isolated system towards a successful radiotherapy treatment.Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patientsMulticenter trials using ¹⁸F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: effects of differential measurement error and bias on power calculations for unselected and enrichment designs.Utility of FDG-PET/CT in the evaluation of the response of locally advanced breast cancer to neoadjuvant chemotherapy18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Positron emission tomography molecular imaging for drug development.Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigmCancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST.Lung [(18)F]fluorodeoxyglucose uptake and ventilation-perfusion mismatch in the early stage of experimental acute smoke inhalationThe role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PETNEO adjuvant chemotherapy in breast cancer: What have we learned so far?Molecular imaging in cancer treatment.Nuclear medicine imaging for prediction or early assessment of response to chemotherapy in patients suffering from breast carcinoma.Positron Emission Tomography (PET) in OncologyRadiobiological Modeling Based on (18)F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer.PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.Molecular imaging of gene expression and protein function in vivo with PET and SPECT.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.Clinical practice guideline for dedicated breast PETAssessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumorOncogene pathway activation in mammary tumors dictates FDG-PET uptakeTBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.The role of PET in monitoring therapy.Design considerations for using PET as a response measure in single site and multicenter clinical trials.The role of (18)F-FDG positron emission tomography in the follow-up of liver tumors treated with (90)Yttrium radioembolization.
P2860
Q24810786-5FD8DA39-B502-479C-89A5-27F87A64833FQ26768486-B224FC4F-BF1D-4103-835D-5E0EAB6FFB11Q27009240-57E94489-1382-4F95-B4DB-643E329D64B8Q27694674-0B882BD1-0B1F-45B8-BCE2-0B1D3DBA16ABQ28076500-6B89F884-8C90-43D7-BC52-240F68AFF02DQ28080621-330034B8-0163-4607-AB1C-EA86A1B24F79Q28354052-71EE92A9-67E5-491D-8922-112D86B6C688Q28710339-D84C62C3-2C98-4C1B-A8F5-7AA08CCED803Q30582277-2D456E2E-CA65-4D81-8569-CC6BC42A675EQ30983527-47EB02DF-45D8-4B2D-9F3E-9327815D7E3AQ33243608-F751DEC3-D180-45C8-B810-6A71F47716B1Q33369337-B1660890-34F6-4124-80E7-3F0742BD882BQ33670107-EEEDB7CC-CBCC-453E-B3DC-9D7762DED11AQ33688715-E3CED313-727F-4DEE-A3C9-9A44635A5178Q33706999-3D748B0B-92FA-40B8-B178-EE29A54CE795Q33838696-65D8BB1B-ABEE-46E3-984D-7D4E04373489Q33847261-9ED48F68-2AEC-4826-A5F9-61F27DBCD529Q33921056-D4D50963-CC7D-4F24-BCFB-23FC625C69EBQ33966252-590917E9-25C3-4758-99D3-7663E6C8B7A9Q33973367-1AC06EE1-214A-4CC0-90D5-328D8B0FE4BEQ33991881-78CCC3DC-C1A8-4CBC-BDED-8BB9357BB93AQ33994282-E0F7907D-FD5A-4B63-8604-205B476F52ABQ34023973-5C64C7BA-141D-4996-82B9-B0788919E3B6Q34030972-5614B00E-516B-4CC5-A934-781CA13A06CBQ34048123-875DBFE6-8B71-492B-A145-476030DFBB3BQ34138174-8A25D484-FC0E-446A-B360-60570341F5BBQ34496670-88B9F0EE-B782-441B-8DAA-D22906753E18Q34680427-78280A51-77B2-4144-88AE-440F71357318Q34774840-E311BCCE-1860-4A1D-B720-50A755F3464BQ34858176-AC262B66-80B3-4D7D-8DFC-CAA7CD054CE1Q34914187-7988F3B4-5980-4122-BD7B-334B8BAF8049Q34918519-F2FED0EB-22CD-47B6-95D8-AE404FB02838Q34978457-80625BBC-B343-47FF-8211-4BBF3EE4C06FQ35083649-16D495D8-7474-4BB7-85C5-A349BDFF6A76Q35111997-F624E70A-E8B2-4B79-81E6-8194D7232398Q35125252-A7B8DD40-1350-43E6-838C-1BD32515FD82Q35155635-871EF5D4-1C54-4C5B-8D05-AD24046F3261Q35172974-2E6822F1-76A7-484A-8344-BC8744B400CCQ35653277-790CFAF8-0F37-430B-963A-FE1FDE84D12AQ35656582-FA60D4B1-F7C1-48C9-A827-940E2AD41FBD
P2860
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Metabolic monitoring of breast ...... omography: initial evaluation.
@en
Metabolic monitoring of breast ...... omography: initial evaluation.
@nl
type
label
Metabolic monitoring of breast ...... omography: initial evaluation.
@en
Metabolic monitoring of breast ...... omography: initial evaluation.
@nl
prefLabel
Metabolic monitoring of breast ...... omography: initial evaluation.
@en
Metabolic monitoring of breast ...... omography: initial evaluation.
@nl
P2093
P1476
Metabolic monitoring of breast ...... omography: initial evaluation.
@en
P2093
P304
P356
10.1200/JCO.1993.11.11.2101
P407
P577
1993-11-01T00:00:00Z